Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.
Mariotti J, Bramanti S, Devillier R, Furst S, El Cheikh J, Sarina B, Granata A, Faucher C, Harbi S, Morabito L, Weiller PJ, Chabannon C, Mokart J, Mineri R, Carlo-Stella C, Santoro A, Blaise D, Castagna L. Mariotti J, et al. Among authors: faucher c. Bone Marrow Transplant. 2018 Mar;53(3):366-370. doi: 10.1038/s41409-017-0032-1. Epub 2017 Dec 21. Bone Marrow Transplant. 2018. PMID: 29269800 No abstract available.
Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.
Castagna L, Crocchiolo R, Furst S, Bramanti S, El Cheikh J, Sarina B, Granata A, Mauro E, Faucher C, Mohty B, Harbi S, Chabannon C, Carlo-Stella C, Santoro A, Blaise D. Castagna L, et al. Among authors: faucher c. Biol Blood Marrow Transplant. 2014 May;20(5):724-9. doi: 10.1016/j.bbmt.2014.02.001. Epub 2014 Feb 13. Biol Blood Marrow Transplant. 2014. PMID: 24530426 Free article.
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Mariotti J, Devillier R, Bramanti S, Sarina B, Furst S, Granata A, Faucher C, Harbi S, Morabito L, Chabannon C, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D, Castagna L. Mariotti J, et al. Among authors: faucher c. Biol Blood Marrow Transplant. 2018 Mar;24(3):627-632. doi: 10.1016/j.bbmt.2017.11.030. Epub 2017 Nov 29. Biol Blood Marrow Transplant. 2018. PMID: 29197681 Free article. Clinical Trial.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Devillier R, Legrand F, Rey J, Castagna L, Fürst S, Granata A, Charbonnier A, Harbi S, d'Incan E, Pagliardini T, Faucher C, Lemarie C, Saillard C, Calmels B, Mohty B, Maisano V, Weiller PJ, Chabannon C, Vey N, Blaise D. Devillier R, et al. Among authors: faucher c. Biol Blood Marrow Transplant. 2018 Jul;24(7):1449-1454. doi: 10.1016/j.bbmt.2018.02.002. Epub 2018 Feb 12. Biol Blood Marrow Transplant. 2018. PMID: 29448057 Free article.
Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.
Debals-Gonthier M, Siani C, Faucher C, Touzani R, Lemarié-Basset C, Chabannon C, Furst S, Devillier R, Harbi S, Castagna L, Caymaris L, Blaise D, Le Corroller Soriano AG. Debals-Gonthier M, et al. Among authors: faucher c. Bone Marrow Transplant. 2018 Sep;53(9):1096-1104. doi: 10.1038/s41409-018-0133-5. Epub 2018 Mar 9. Bone Marrow Transplant. 2018. PMID: 29523885
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients.
Pagliardini T, Harbi S, Fürst S, Castagna L, Legrand F, Faucher C, Granata A, Weiller PJ, Calmels B, Lemarie C, Chabannon C, Bouabdallah R, Mokart D, Vey N, Blaise D, Devillier R. Pagliardini T, et al. Among authors: faucher c. Bone Marrow Transplant. 2019 Jul;54(7):1067-1076. doi: 10.1038/s41409-018-0387-y. Epub 2018 Nov 6. Bone Marrow Transplant. 2019. PMID: 30401970 Clinical Trial.
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.
Mariotti J, Granata A, Bramanti S, Devillier R, Furst S, Sarina B, Harbi S, Legrand F, Faucher C, Weiller PJ, Chabannon C, Carlo-Stella C, Santoro A, Blaise D, Castagna L. Mariotti J, et al. Among authors: faucher c. Bone Marrow Transplant. 2019 Jul;54(7):1164-1167. doi: 10.1038/s41409-019-0453-0. Epub 2019 Jan 24. Bone Marrow Transplant. 2019. PMID: 30679826 Clinical Trial.
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.
Granata A, Fürst S, Bramanti S, Legrand F, Sarina B, Harbi S, De Philippis C, Faucher C, Chabannon C, Lemarie C, Calmels B, Mariotti J, Maisano V, Weiller PJ, Mokart D, Vey N, Bouabdallah R, Castagna L, Blaise D, Devillier R. Granata A, et al. Among authors: faucher c. Bone Marrow Transplant. 2019 Nov;54(11):1730-1737. doi: 10.1038/s41409-019-0500-x. Epub 2019 Mar 19. Bone Marrow Transplant. 2019. PMID: 30890770
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.
Mariotti J, Devillier R, Bramanti S, Giordano L, Sarina B, Furst S, Granata A, Maisano V, Pagliardini T, De Philippis C, Kogan M, Faucher C, Harbi S, Chabannon C, Carlo-Stella C, Bouabdallah R, Santoro A, Blaise D, Castagna L. Mariotti J, et al. Among authors: faucher c. Biol Blood Marrow Transplant. 2019 Sep;25(9):1810-1817. doi: 10.1016/j.bbmt.2019.05.017. Epub 2019 May 22. Biol Blood Marrow Transplant. 2019. PMID: 31128326 Free article. Clinical Trial.
240 results